D1R-5-HT2AR Uncoupling Reduces Depressive Behaviours via HDAC Signalling

Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455(7215):894–902.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willner P, Scheel-Krüger J, Belzung C. The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev. 2013;37(10 Pt 1):2331–71.

Article  CAS  PubMed  Google Scholar 

Duman RS. Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections. Depress Anxiety. 2014;31(4):291–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Block SG, Nemeroff CB. Emerging antidepressants to treat major depressive disorder. Asian J Psychiatr. 2014;12:7–16.

Article  PubMed  Google Scholar 

Niederkofler V, Asher TE, Dymecki SM. Functional interplay between dopaminergic and serotonergic neuronal systems during development and adulthood. ACS Chem Neurosci. 2015;6(7):1055–70.

Article  CAS  PubMed  Google Scholar 

Di Matteo V, Di Giovanni G, Pierucci M, Esposito E. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Prog Brain Res. 2008;172:7–44.

Article  PubMed  Google Scholar 

Hyman SE. Neurotransmitters. Curr Biol. 2005;15(5):R154–8.

Article  CAS  PubMed  Google Scholar 

Belujon P, Grace AA. Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol. 2017;20(12):1036–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG. Dopamine: functions, signaling, and association with neurological diseases. Cell Mol Neurobiol. 2019;39(1):31–59.

Article  PubMed  Google Scholar 

Felger JC. The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications. Curr Top Behav Neurosci. 2017;31:199–219.

Article  CAS  PubMed  Google Scholar 

Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry. 2008;69(Suppl E1):4–7.

PubMed  Google Scholar 

Dixon ML, Thiruchselvam R, Todd R, Christoff K. Emotion and the prefrontal cortex: An integrative review. Psychol Bull. 2017;143(10):1033–81.

Article  PubMed  Google Scholar 

Kram ML, Kramer GL, Ronan PJ, Steciuk M, Petty F. Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(4):639–45.

Article  CAS  PubMed  Google Scholar 

Du H, Deng W, Aimone JB, Ge M, Parylak S, Walch K, et al. Dopaminergic inputs in the dentate gyrus direct the choice of memory encoding. Proc Natl Acad Sci U S A. 2016;113(37):E5501–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Aquila PS, Collu M, Pani L, Gessa GL, Serra G. Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression. Eur J Pharmacol. 1994;262(1–2):107–11.

Article  CAS  PubMed  Google Scholar 

Tyler CR, Solomon BR, Ulibarri AL, Allan AM. Fluoxetine treatment ameliorates depression induced by perinatal arsenic exposure via a neurogenic mechanism. Neurotoxicology. 2014;44:98–109.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Demontis F, Serra F, Serra G. Antidepressant-induced dopamine receptor dysregulation: a valid animal model of manic-depressive illness. Curr Neuropharmacol. 2017;15(3):417–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry. 2004;6(4):159–66.

PubMed  PubMed Central  Google Scholar 

Carhart-Harris RL, Nutt DJ. Serotonin and brain function: a tale of two receptors. J Psychopharmacol. 2017;31(9):1091–120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murnane KS. Serotonin 2A receptors are a stress response system: implications for post-traumatic stress disorder. Behav Pharmacol. 2019;30(2 and 3 Spec Issue):151–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bankson MG, Cunningham KA. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J Pharmacol Exp Ther. 2001;297(3):846–52.

CAS  PubMed  Google Scholar 

Pitts EG, Minerva AR, Chandler EB, Kohn JN, Logun MT, Sulima A, et al. 3,4-Methylenedioxymethamphetamine increases affiliative behaviors in squirrel monkeys in a serotonin 2A receptor-dependent manner. Neuropsychopharmacology. 2017;42(10):1962–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Egerton A, Ahmad R, Hirani E, Grasby PM. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat. Psychopharmacology. 2008;200(4):487–96.

Article  CAS  PubMed  Google Scholar 

Schmidt CJ, Fadayel GM. The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur J Pharmacol. 1995;273(3):273–9.

Article  CAS  PubMed  Google Scholar 

Marek GJ, Carpenter LL, McDougle CJ, Price LH. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology. 2003;28(2):402–12.

Article  CAS  PubMed  Google Scholar 

Celada P, Puig M, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci. 2004;29(4):252–65.

PubMed  PubMed Central  Google Scholar 

Borroto-Escuela DO, Tarakanov AO, Fuxe K. FGFR1-5-HT1A heteroreceptor complexes: implications for understanding and treating major depression. Trends Neurosci. 2016;39(1):5–15.

Article  CAS  PubMed  Google Scholar 

Borroto-Escuela DO, Narváez M, Ambrogini P, Ferraro L, Brito I, Romero-Fernandez W, et al. Receptor–receptor interactions in multiple 5-HT1A heteroreceptor complexes in raphe-hippocampal 5-HT transmission and their relevance for depression and its treatment. Molecules (Basel, Switzerland). 2018;23(6).

Pei L, Li S, Wang M, Diwan M, Anisman H, Fletcher PJ, et al. Uncoupling the dopamine D1–D2 receptor complex exerts antidepressant-like effects. Nat Med. 2010;16(12):1393–5.

Article  CAS  PubMed  Google Scholar 

Cao X, Li LP, Wang Q, Wu Q, Hu HH, Zhang M, et al. Astrocyte-derived ATP modulates depressive-like behaviors. Nat Med. 2013;19(6):773–7.

Article  CAS  PubMed  Google Scholar 

Li W, Ali T, Zheng C, Liu Z, He K, Shah FA, et al. Fluoxetine regulates eEF2 activity (phosphorylation) via HDAC1 inhibitory mechanism in an LPS-induced mouse model of depression. J Neuroinflammation. 2021;18(1):38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Ali T, He K, Liu Z, Shah FA, Ren Q, et al. Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression. Brain Behav Immun. 2020.

Ali T, Rahman SU, Hao Q, Li W, Liu Z, Ali Shah F, et al. Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation. J Pineal Res. 2020;69(2):e12667.

Article  CAS  PubMed  Google Scholar 

Ali T, Hao Q, Ullah N, Rahman SU, Shah FA, He K, et al. Melatonin act as an antidepressant via attenuation of neuroinflammation by targeting Sirt1/Nrf2/HO-1 signaling. Front Mol Neurosci. 2020;13:96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64(3):327–37.

Article  CAS  PubMed  Google Scholar 

Dudman JT, Eaton ME, Rajadhyaksha A, Macías W, Taher M, Barczak A, et al. Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem. 2003;87(4):922–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kojima N, Shirao T. Synaptic dysfunction and disruption of postsynaptic drebrin-actin complex: a study of neurological disorders accompanied by cognitive deficits. Neurosci Res. 2007;58(1):1–5.

Article  CAS  PubMed  Google Scholar 

Bilbao A, Rieker C, Cannella N, Parlato R, Golda S, Piechota M, et al. CREB activity in dopamine D1 receptor expressing neurons regulates cocaine-induced behavioral effects. Front Behav Neurosci. 2014;8:212.

PubMed  PubMed Central 

Comments (0)

No login
gif